New adaptive clinical trial aims to reverse neurological damage caused by progressive multiple sclerosis
Can't see this email? View it online
   
  Multiple Sclerosis  
  The latest multiple sclerosis news from News Medical  
 Small molecule drug shows promise as potential new treatment for multiple sclerosisSmall molecule drug shows promise as potential new treatment for multiple sclerosis
 
CAMH-led pre-clinical studies using a small molecule drug have shown promise as a potential new treatment for multiple sclerosis (MS). The results have been published today in the journal Science Advances.
 
 
 Study suggests possible targets for the development of a vaccine against multiple sclerosisStudy suggests possible targets for the development of a vaccine against multiple sclerosis
 
Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease in which the Epstein-Barr virus (EBV) is thought to play a role that has not yet been fully clarified.
 
   Depression, constipation, and UTIs may be early signs of multiple sclerosisDepression, constipation, and UTIs may be early signs of multiple sclerosis
 
In some diseases, the underlying processes can start years before a diagnosis is made. A new study finds that people who later develop multiple sclerosis (MS) are more likely to have conditions like depression, constipation and urinary tract infections five years before their MS diagnosis than people who do not develop MS.
 
   Novel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytesNovel molecular link between vitamin B12 and multiple sclerosis revealed in astrocytes
 
For decades, scientists have noted an intriguing similarity between a deficiency in vitamin B12 – an essential nutrient that supports healthy development and functioning of the central nervous system (CNS) – and multiple sclerosis (MS), a chronic disease in which the body's immune system attacks the CNS and which can produce neurodegeneration.
 
 New adaptive clinical trial aims to reverse neurological damage caused by progressive multiple sclerosis
 
New adaptive clinical trial aims to reverse neurological damage caused by progressive multiple sclerosisThe first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
 
 
 EU funds the international "BEHIND-MS" consortium to tackle multiple sclerosis
 
EU funds the international "BEHIND-MS" consortium to tackle multiple sclerosisMultiple sclerosis (MS), an inflammatory disease of the central nervous system, affects more than 1 million people in Europe and an estimated 2.8 million worldwide.